Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px
Organisation › Details

Merus (Group)

Merus is a Dutch biotechnology company developing cancer therapeutics based on human bispecific antibodies. Merus’ bispecific antibodies have the robust and proven full-length IgG format, they are manufactured using industry standard processes and have predictable in vivo behavior such as long half-life and low immunogenicity. Merus has two lead programs in development, MCLA-128 for the treatment of HER2 expressing solid tumors, and MCLA-117 for the treatment of acute myeloid leukemia and myelodysplastic syndrome. The company is also developing a broad pipeline of preclinical programs in immuno-oncology using its unique technology platforms. *


Period Start 2006-01-17 existent
  Today Merus B.V.
Product Industry  MeMo™ humanized mouse antibody platform
Region Region Utrecht
  Country Netherlands
Basic data Employees n. a.
  Currency EUR
  Annual sales 1,977,000 (revenue (2015) 2015-12-31)
  Profit -23,184,000 (2015-12-31)
  Cash 32,851,000 (2015-12-31)
    * Document for �About Section�: Selexis S.A.. (5/20/15). "Press Release: Merus and Selexis Receive a €2.1 Million Grant for Single Cell Line Manufacturing of a Bispecific Antibody Combination to Treat Colorectal Cancer". Geneva.
Record changed: 2018-10-31


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Merus (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px

» top